Tech Transfer: Herpes Treatment

Guests: Matt Cryer, CEO of KP Biosciences; Dave Brown, Associate Director of BYU's Technology Transfer Office It’s not talked about much and there’s no cure for it, but genital herpes is increasingly prevalent. The CDC says three-quarters of a million people come down with a new infection of it every year. It’s highly contagious – even when the infected person is showing no visible symptoms. Drugs to treat genital herpes primarily limit outbreaks of painful and unsightly sores and lesions.